Pyxis Oncology Inc (PYXS) — Strategic Asset Allocation Index
Pyxis Oncology Inc (PYXS) has a Strategic Asset Allocation Index of 17.8% as of June 2023. Strategic assets (PP&E of $25.93 Million plus long-term investments of $-) total $25.93 Million, measured against net assets of $145.28 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Pyxis Oncology Inc to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Pyxis Oncology Inc Strategic Asset Allocation Index (2021–2022)
This chart shows how Pyxis Oncology Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2021 to 2022. As of June 2023, the index stands at 17.8%, representing strategic assets of $25.93 Million against net assets of $145.28 Million USD. For live market cap and overall valuation, see PYXS stock market capitalisation.
Annual Strategic Asset Allocation Index for Pyxis Oncology Inc (2021–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Pyxis Oncology Inc from 2021 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of Pyxis Oncology Inc for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 6.9% | $11.16 Million | $11.16 Million | $- | $160.82 Million | ▲ +6.6 pp |
| 2021 | 0.4% | $1.01 Million | $1.01 Million | $- | $261.31 Million | — |